Carlyle Group Inc.'s stock fell 5% on Tuesday after the private-equity firm signaled a slowdown in its fee-related earnings growth in 2025, as it leans on its private-credit arm to increase its profit ...

Technologies (NASDAQ: DVAX) fell 6% Tuesday after Goldman Sachs issued a rare "sell" rating on the biopharmaceutical company, ...

Shares of Axsome Therapeutics ( AXSM 4.36%) are up on Tuesday. The company's stock gained 4.1% as of 10:20 a.m. ET, but was ...

Goldman Sachs will drop a demand that corporate boards of directors include women and members of minority groups as financial ...

A top Wells Fargo executive said on Tuesday that the bank has five consent orders remaining to resolve issues related to its lending and sales practices, and he added the recent termination of three ...

While the world scrutinizes Donald Trump's economic policies and China's progress in AI, European stock markets are in ...

If you need to generate income from your investments, selecting securities or funds based on their current interest or dividend payouts might solve the immediate problem. But a strategy of increasing ...

Goldman Sachs would consider acquisitions in asset and wealth management, but the bar for doing a deal is very high, CEO ...

The stock market has a long history of creating wealth for investors. Companies that have a record of strong growth with ...

More than 60% of the S&P-listed companies have reported earnings, and the results are well above expectations. It’s safe to ...

Goldman Sachs downgraded Dynavax Technologies Corporation (NASDAQ:DVAX) stock from Neutral to Sell, adjusting the price target downward to $12.00 from the previous $15.00. According to InvestingPro ...

Goldman Sachs (NYSE: GS) has faced its share of challenges in recent years, primarily stemming from a slowdown in capital market activities like mergers and acquisitions and initial public offerings ...